Dysbindin in epithelial ovarian cancer increases tumor cell invasion and metastasis by activating extracellular signal-regulated kinase (ERK) phosphorylation and triggering the epithelial-mesenchymal transition [17]. Here, DTNBP1 is linked to neoplasm.